Health Benefits, Risks, and Cost-Effectiveness of Influenza Vaccination of Children

We estimated cost-effectiveness of annually vaccinating children not at high risk with inactivated influenza vaccine (IIV) to range from US $12,000 per quality-adjusted life year (QALY) saved for children ages 6–23 months to $119,000 per QALY saved for children ages 12–17 years. For children at high...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Prosser, Lisa A., Bridges, Carolyn Buxton, Uyeki, Timothy M., Hinrichsen, Virginia L., Meltzer, Martin I., Molinari, Noelle-Angelique M., Schwartz, Benjamin, Thompson, William W., Fukuda, Keiji, Lieu, Tracy A.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Centers for Disease Control and Prevention 2006
Schlagworte:
Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3290928/
https://ncbi.nlm.nih.gov/pubmed/17176570
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid1210.051015
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge